Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Industry News
Share your love
Oculus, Mainline Instruments Forge UK, Ireland Distribution Pact
In a move signaling a strategic expansion, Mainline Instruments and Oculus Optikgeräte have announced the extension of their successful partnership into the ophthalmology sector for the UK and Ireland markets. This collaboration aims to introduce cutting-edge ophthalmic solutions, catering to…
2023 Recap: Top 10 Acquisitions in the Ophthalmic Industry
In 2023, the ophthalmic industry witnessed a transformative landscape shaped by strategic company acquisitions, setting the stage for significant advancements and collaborations. The top 10 acquisitions of the year highlighted a dynamic shift in the competitive dynamics of the sector.…
Meridian Medical Introduces Ophthalmic Laser Line in US
Meridian Medical, headquartered in Switzerland, announced the launch of its line of ophthalmic lasers in the United States, following a series of FDA approvals. The FDA approval, received on January 25, includes the MR Q family of lasers, which offer…
FDA Gives Green Light to OK-101 Trial for NCP Treatment
Okyo Pharma’s first investigational new drug (IND) application for OK-101 has been cleared by the U.S. Food and Drug Administration (FDA), marking a pivotal moment in the development of potential therapies for neuropathic corneal pain. Initially proposed as an open-label…
New Features at ESCRS Winter Meeting in Frankfurt
The European Society of Cataract and Refractive Surgeons (ESCRS) Winter Meeting in Frankfurt at Congress Centre Messe Frankfurt, scheduled for February 15-18, 2024, promises an array of new sessions and activities aimed at fostering collaboration, learning, and networking within the…
Glaukos Secures FDA Approval for iDose TR
Glaukos has received FDA approval for iDose TR (travoprost intracameral implant 75 mcg), a groundbreaking prostaglandin analog intracameral implant designed to reduce intraocular pressure (IOP) in individuals with ocular hypertension or open-angle glaucoma. The iDose TR procedure, sanctioned for a…
Eyenovia’s Mydcombi Approved by the FDA
Eyenovia Inc. announced that the FDA has approved Mydcombi, a groundbreaking ophthalmic spray that induces mydriasis for diagnostic procedures and short-term pupil dilation. This marks the first approved, fixed-dose combination of tropicamide and phenylephrine in the United States and also…
Top 10 Trends to Watch in Ophthalmology
The field of ophthalmology is constantly evolving with new technologies and treatments emerging every year. In the next decade, we can expect even more advancements that will revolutionize the way we approach eye care. Here are the top 10 eye…
Japanese Astellas Pharma Acquires Iveric Bio for $5.9 Billion
Astellas Pharma, a Japanese drugmaker, announced the acquisition of Iveric Bio, a pharmaceutical company that is currently in the late stages of developing a geographic atrophy drug. The acquisition is valued at $5.9 billion, and under the terms of the…
Ophthalmology’s Leap with Emerging Technologies
In a recent survey conducted on LinkedIn by the Ophthalmology Breaking News (OBN), ophthalmology professionals were asked to identify the emerging technology they believed held the most promise for improving surgical outcomes in their field. The results shed light on…